Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304644 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Joseph Walden und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Child Health Equity and Outcomes Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United S…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hydroxyurea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Sickle cell disease (SCD) is an inherited blood disorder that affects approximately 100,000 Americans, primarily from underrepresented racial minority populations, and results in costly, multi-organ complications. Hydroxyurea, the primary disease-modifying therapy for SCD, is effective at reducing most complications; however, adherence to hydroxyurea remains suboptimal and is the primary barrier to clinical effectiveness. Video directly observed therapy (VDOT) has shown promise as an adherence-promoting intervention for hydroxyurea, yet previous VDOT trials were limited by high attrition from gaps in technology access, use of unvalidated adherence measures, and healthcare system limitations of delivering VDOT to patients. As such, we fostered a small business partnership to compare VDOT for hydroxyurea to attention control to address previous shortcomings, promote equitable trial participation, and maximize scalability. VDOT will be administered by Scene Health (formerly emocha Health) and adherence monitoring will be performed using a novel electronic adherence monitor developed to meet the unique needs of the target population. Adolescent and young adult patients as well as caregivers of younger patients (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Child Health Equity and Outcomes Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States of America.
- emocha Mobile Health Inc. Doing Business as Scene and Scene Health, Baltimore, MD, United States of America.
- Center for Biobehavioral Health, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States of America.
- Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
- Division of Hematology, Oncology, and Stem Cell Transplant, Lurie Children's Hospital of Chicago, Chicago, IL, United States of America.
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.
ORCID-Profile: Joseph Walden, Susan Creary
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Walden, J., Brown, L., Seiguer, S., Munshaw, K., Rausch, J., Badawy, S., McGann, P., Winkler, S., Gonzalez, L., & Creary, S. (2024). Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0304644
Vancouver
Walden J, Brown L, Seiguer S, Munshaw K, Rausch J, Badawy S, et al. Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0304644
BibTeX
@article{Walden2024,
author = {Walden, Joseph and Brown, Lauren and Seiguer, Sebastian and Munshaw, Katie and Rausch, Joseph and Badawy, Sherif and McGann, Patrick and Winkler, Savannah and Gonzalez, Lisbel and Creary, Susan},
title = {Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304644}
}
EUVIMED